| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaacc8dd0526bcb05da49300b45ddcf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb64198e5b9105e8867d0c5dbcd80699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d075133e905eb1436a212931a5d3eb39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e33c2bde5405bd266bba10a88dcdb6cc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db408efe7172d8dc41413f88552a40a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177190c64d6fbcf013e93483e3854ed8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a094ce1fadebb6b43f091da8cc55857 |
| publicationDate |
2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012088232-A1 |
| titleOfInvention |
Aptamer-Based Device For Detection Of Cancer Markers And Methods Of Use |
| abstract |
Systems and methods are provided for detecting and quantitating one or more compounds or molecules in a sample. An aptamer-based point-of-care device (such as a strip) is described for rapid detection of target molecules such as the cancer marker p-glycoprotein (Pgp). Fluorescent molecules or gold nanoparticles may be used to detect the binding between a target molecule and the aptamer. By way of example, fluorescence resonance energy transfer (FRET) or Dynamic Light Scattering (DLS) may be used for detecting the physical and/or chemical changes caused by the binding of the aptamers to the target molecules. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016507063-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110441508-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014123430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016149253-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111304208-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105928920-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102879366-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023869-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844386-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104502585-A |
| priorityDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |